GlassScriptPhysician profile
Merry Ruan
NPI 1770043473
$3,644.31
in general payments reported to CMS, 2019-2025
11 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $790 · 2024: $1,408 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,519.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,292.71 | 2022-2025 | Hydrus Microstent, Clareon, Clareon Panoptix Pro |
| Abbvie INC. | $683.13 | 2023-2025 | Xen Glaucoma Treatment System |
| Sight Sciences, INC. | $654.36 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| New World Medical,INC. | $477.87 | 2023-2025 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Dompe US, INC. | $172.54 | 2025 | Oxervate |
| Glaukos Corporation | $148.54 | 2023-2025 | Idosetr |
| Tarsus Pharmaceuticals, INC. | $73.51 | 2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $56.14 | 2025 | Tecnis Simplicity |
| Rxsight INC | $44.02 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Oyster Point Pharma, INC. | $24.93 | 2023 | Tyrvaya |
| Thea Pharma INC. | $16.56 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merry Ruan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.